Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Utah for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Utah only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Utah (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ryan Isom (NPI 1679756019)

Field	Value
Entity Type	Individual
Organization	Ryan Isom
Address	1055 N 300 W Ste 500
City	Provo
State	UT
ZIP	84604
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	December 7, 2007

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider reports Total Medicare revenue: $3.7M and has no Medicaid billing on file, making the practice effectively single‑payer (Medicare) in the available data. The absence of any Medicaid activity suggests payer mix is highly concentrated and any Medicaid-facing strategy or network participation is not visible in these claims.

Revenue is highly concentrated in a small set of drug and procedure codes: the precomputed top 3 Medicare codes account for 84.6% of this provider's total Medicare revenue. The three leading codes include J0178 ($2.6M revenue, 3.8K claims, $686 avg paid/claim, 69.7% of this provider's total Medicare revenue), J3490 ($368.4K revenue, 183 claims, $2013 avg paid/claim, 9.9%), and 67028 ($188.6K revenue, 2K claims, $93 avg paid/claim, 5.1%), indicating a narrow set of services driving most payments.

The mix of top codes indicates a medical‑retina, injection‑centric practice: large volumes of intravitreal pharmacotherapy (J0178 and J2781), supplemental compounded or unclassified drug billing (J3490 and J7999), and frequent retinal imaging (92134). High counts for 92134 (2.6K claims, $75.1K revenue) and 92201 (1.6K claims, $29.7K revenue) alongside dominant injection codes support a workflow focused on repeat injection visits plus diagnostic imaging rather than primarily surgical case volume.

J0178 is the single dominant revenue driver and is reported as notably above typical national volume: it accounts for $2.6M revenue and 3.8K claims and ranks #87 of 3204 providers nationally (97th percentile; notably above typical national volume for this code). That rank and dollar share show this provider is a high‑volume national participant for aflibercept administration relative to peers.

Several encounter and diagnostic codes are flagged as statistical outliers, implying elevated visit and testing throughput: 99214 is reported as an "extreme outlier, far above typical national volume" (1.8K claims, $160.8K revenue), 92134 is an "extreme outlier" (2.6K claims, $75.1K), and 92201 ranks in the 99th percentile as an "extreme outlier" (1.6K claims, $29.7K). These patterns point to unusually high per‑provider volumes of E/M visits and retinal diagnostics compared with national peers.

Not all high‑revenue items are atypical: J3490 (183 claims, $368.4K revenue, ranked in the 87th percentile and described as typical, unremarkable volume) and J2781 (1.2K claims, $142.2K revenue, described as typical, unremarkable volume) are sizable contributors but are characterized in the data as within expected ranges for peers. This suggests the practice pairs one very large, above‑typical revenue stream (J0178) with several other drug services at normal peer volumes.

Surgical retina procedures are present but limited in scale and account for a small share of revenue: codes such as 67041 ($20.4K revenue, 24 claims), 67113 ($12.6K revenue, 13 claims), and 67042 ($10.2K revenue, 13 claims) appear infrequently and rank at middling or lower national percentiles. The low claim counts and modest revenue for these surgical codes reinforce that the provider operates primarily as a medical retina/injection practice rather than a high‑volume surgical center.

The provider has longstanding enrollment: NPI enumerated (registered) 2007-12-07 (~19 years ago). That nearly two‑decade tenure, combined with very high volume on injection and diagnostic codes, is consistent with an established referral base and an operational model optimized for recurrent intravitreal therapy visits and imaging follow‑up.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,790	$690	$2.6M
J3490	Unclassified drugs	180	$2,010	$368.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,030	$90	$188.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,810	$90	$160.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,190	$120	$142.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,590	$30	$75.1K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	250	$160	$40.1K
92201	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	1,650	$20	$29.7K
J7999	Compounded drug, not otherwise classified	360	$70	$26.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	430	$60	$23.4K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Utah Distribution

Ryan Isom — 7 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Utah

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	40	620	$690	$683.2K
J3490	6	30	80	$1,690	$199.5K
J2781	5	20	960	$120	$126.6K
67028	3	60	440	$90	$61.7K
J7312	6	10	340	$160	$52.7K
67041	4	10	20	$1,040	$28.2K
67042	11	20	20	$1,100	$26.3K
67036	14	20	20	$1,010	$24.2K
67113	4	10	20	$1,170	$20K
J7999	3	20	120	$70	$16.9K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ryan Isom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ihc Health Services, Inc.	UT	Children's Hospital	$0	$129.5M
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$68.7M
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$65.8M
Ihc Health Services Inc	UT	General Acute Care Hospital	$0	$54.1M
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$44.3M
Ihc Health Services Inc	UT	Home Infusion Therapy Pharmacy	$0	$38.1M
Ihc Health Services Inc	UT	Durable Medical Equipment & Medical Supplies	$0	$26.9M
Ihc Health Services Inc	UT	General Acute Care Hospital	$0	$25.3M
Ihc Health Services, Inc.	UT	Clinical Medical Laboratory	$2.7M	$17.9M
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$20.4M

Nearby Providers

Other providers in the same ZIP code as Ryan Isom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Revere Health PC	UT	Multi-Specialty Clinic/Center	$0	$24M
Utah Valley Pediatrics L.L.C.	UT	Pediatrics Physician	$0	$11.9M
Riverwoods Surgery Center, LLC	UT	Ambulatory Surgical Clinic/Center	$737.9K	$5M
Utah Valley Emergency Physicians Inc	UT	Emergency Medicine Physician	$0	$4.7M
Jack Stringham	UT	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Ihc Health Services Inc	UT	Durable Medical Equipment & Medical Supplies	$0	$3.3M
Richard Corey	UT	Retina Specialist (Ophthalmology) Physician	$3M	$50.1K
Provo City Board Of Education	UT	Local Education Agency (LEA)	$0	$3M
Robert Welch	UT	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Jonathan Gunther	UT	Retina Specialist (Ophthalmology) Physician	$2.3M	$3K

Ryan Isom — Billing Profile & Reimbursement Data

Sign up for Ryan Isom — Billing Profile & Reimbursement Data policy alerts

Ryan Isom — Billing Profile & Reimbursement Data

Sign up for Ryan Isom — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References